<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07297763</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>5 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>70 </s211>
<s212>PRT </s212>
<s213>Homo sapiens </s213>
</s200>
<s400> 1 
Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln 
  1               5                  10                  15 
Phe Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly 
                 20                  25                  30 
Tyr Gly Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Ile Val Asp 
                 35                  40                  45 
Glu Cys Cys Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr 
                 50                  55                  60 
Cys Ala Pro Leu Lys Pro Ala Lys Ser Ala 
                 65                  70 
</s400>
<s200>
<s210>2 </s210>
<s211>67 </s211>
<s212>PRT </s212>
<s213>Homo sapiens </s213>
</s200>
<s400> 2 
Ala Tyr Arg Pro Ser Glu Thr Leu Cys Gly Gly Glu Leu Val Asp 
  1               5                  10                  15 
Thr Leu Gln Phe Val Cys Gly Asp Arg Gly Phe Tyr Phe Ser Arg 
                 20                  25                  30 
Pro Ala Ser Arg Val Ser Arg Arg Ser Arg Gly Ile Val Glu Glu 
                 35                  40                  45 
Cys Cys Phe Arg Ser Cys Asp Leu Ala Leu Leu Glu Thr Tyr Cys 
                 50                  55                  60 
Ala Thr Pro Ala Lys Ser Glu 
                 65 
</s400>
<s200>
<s210>3 </s210>
<s211>50 </s211>
<s212>PRT </s212>
<s213>Homo sapiens </s213>
</s200>
<s400> 3 
Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu 
  1               5                  10                  15 
Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Gly 
                 20                  25                  30 
Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu 
                 35                  40                  45 
Glu Asn Tyr Cys Asn 
                 50 
</s400>
<s200>
<s210>4 </s210>
<s211>16 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Sequence is synthesized.</s223>
</s220>
</s200>
<s400> 4 
Arg Asn Cys Phe Glu Ser Val Ala Ala Leu Arg Arg Cys Met Tyr 
  1               5                  10                  15 
Gly 
</s400>
<s200>
<s210>5 </s210>
<s211>56 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Residues observed in IGF-1 structure.</s223>
</s220>
</s200>
<s400> 5 
Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln Phe Val 
  1               5                  10                  15 
Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr Gly 
                 20                  25                  30 
Ser Ser Thr Gly Ile Val Asp Glu Cys Cys Phe Arg Ser Cys Asp 
                 35                  40                  45 
Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro Leu 
                 50                  55
</s400>
</sequence-list-new-rules>
</sequence-cwu>
